Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Finasteride may cause long-lasting sexual side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Longer CAG repeats in gene linked to more severe hair loss in females.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.